Clinicopathological characteristics of ovarian carcinomas associated with endometriosis

Introduction Substantial histopathology data provide evidence that endometriosis might be viewed as a precursor lesion of endometrioid and clear cell carcinoma of the ovary, via intermediary atypical borderline lesions. Also, genes involved in both endometriosis and epithelial ovarian cancer have been shown to play a role in the pathogenesis of endometriosis-associated ovarian carcinoma.

A retrospective study of 17 cases of ovarian carcinomas associated with endometriosis, diagnosed between 2000 and 2009, at Aretaieion Hospital of University of Athens, is presented. 10/17 cases in this study (58.8%) were clear cell carcinomas (CCC), 6/17 cases (35.3%) were endometrioid adenocarcinomas (EAC) and 1/17 cases (5.9%) was a serous carcinoma associated with ovarian endometriosis. Patients’s age was 27–76 years (mean age 58 years). Typical ovarian endometriosis was documented in 8/17 (47%) of the tumors. In 9/17 cases, areas of fibrosis or cystic lesions infiltrated by iron-laden macrophages and endometrial-like stroma, consistent with endometriosis, were observed.

In comparison with common epithelial ovarian cancers, CCC and EACs of the ovary were presented at earlier stages. Cytoreductive surgical treatment is critical in order to plan appropriate post-operative management. Similar content being viewed by others

Kaku T, Ogawa S, Kawano Y, Ohishi Y, Kobayashi H, Hirakawa T, Nakano H (2003) Histological classification of ovarian cancer. Med Electron Microsc 36:9–17 Kobayashi H, Kajiwara H, Kanayama S, Yamada Y, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T, Oi H (2009) Molecular pathogenesis of endometriosis- associated clear cell carcinoma of the ovary (Review). Oncol Rep 22:233–240 Crozier MA, Copeland LJ, Silva EG, Gerhenson DM, Stringer CA (1989) Clear cell carcinoma of the ovary: a study of 59 cases. Gynecol Oncol 35:199–203 Varma R, Rollason T, Gupta JK, Maher ER (2004) Endometriosis and the metastatic process. Reproduction 127:293–304 Erzen M, Kovacic J (1998) Relationship between endometriosis and ovarian cancer. Eur J Gynaecol Oncol 19:553 Kurman RJ, Ellenson LH, Ronnett BM (eds) (2011) Blaustein’s pathology of the female genital tract, 6th edn. Springer, New York, pp 647–649 Kobayashi H (2009) Ovarian cancer in endometriosis: epidemiology, natural history and clinical diagnosis. Int J Clin Oncol 14:378–382 Kobayashi H, Sumimoto K, Kitanaka T et al (2008) Ovarian endometrioma—risk factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol 138:187–193 Jimbo H, Yoshikawa H, Onda T et al (1997) Prevalence of ovarian endometriosis in epithelial ovarian cancer. Int J Gynecol Obstet 59:245–250 Sugiyama T, Kamura T, Kigawa J, Terakawa N et al (2000) Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88:2584–2589 Schiller W (1929) Mesonephroma ovarii. Int J Cancer 35:1 Saphir O, Lackner JE (1944) Adenocarcinoma with clear cells (hypernephroid) of ovary. Surg Gynecol Obstet 79:539 Teilum G (1946) Gonocytoma: homologous ovarian and testicular tumors. Acta Pathol Microbiol Scand 23:242 Scully RE (1970) Recent progress in ovarian cancer. Hum Pathol 1:73 Scully RE, Barlos JF (1967) Mesonephroma of the ovary: tumor of mullerian nature related to endometrioid carcinoma. Cancer 20:1405 Shevchuk MM, Winckler-Monsanto B, Fenoglio CM et al (1981) Clear cell carcinoma of the ovary: a clinicopathologic study with review of the literature. Cancer 47:1344 Prowse AH, Manek S, Varma R et al (2006) Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. Int J Cancer 119:556–562 Defrere S, Lousse JC, Gonzalez-Ramos R, Colette S, Donnez J, van Langendonckt A (2008) Potential involvement of iron in the pathogenesis of peritoneal endometriosis. Mol Hum Reprod 14:377–385 Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K, Fujii S (2008) Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the ironinduced persistent oxidative stress. Clin Cancer Res 14:32–40 Zorn KK, Bonome T, Gangi L, Chandramouli GVR, Awtrey CS et al (2005) Gene expression profiles of serous, endometrioid and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res 11(18):6422–6430 Yoshida S, Furukawa N, Haruta S, Tanase Y, Kanayama S, Noguchi T et al (2009) Theoretical model of treatment strategies for clear cell carcinoma of the ovary: focus on perspectives. Cancer Treat Rev 35:608–615 Kurman RJ, Visvanathan K, Roden R, Shih I-M (2008) Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obst Gynecol 4:351–356 Christie M, Oehler MK (2006) Molecular pathology of epithelial ovarian cancer. J Br Menopause Soc 12(2):57–63 Kajihara H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sado T, Oi H, Kobayashi H (2010) Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review). Oncol Rep 23(5):1193–1203 Kato N, Sasou S, Motoyama T (2006) Expression of hepatocyte nuclear factor 1beta (HNF-1b) in clear cell tumors and endometriosis of the ovary. Mod Pathol 19:83–89 Skirnisdottir I, Seidal T, Karlsson MG, Sorbe B (2005) Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I–II. Int J Oncol 26(1):177–183 Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, Noguchi M (2000) Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60:7052–7056 Kurman RJ, Shih I-M (2008) Pathogenesis of ovarian cancer. Lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 27(2):151–160 Keita M, Bessette P, Pelmus M, Ainmelk Y, Aris A (2010) Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes. J Ovarian Res 3:3 Castiblanco GA, Pires NY, Wistuba OI, Riquelme SE, Andrade ML, Corvalan RA (2006) Pathogenetic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis. Rev Med Chil 134(3):271–278 Jenison EL, Montag AG, Griffiths CT, Welch WR, Lavin PT, Greer J, Knapp RC (1989) Clear cell adenocarcinoma of the ovary: a clinical analysis, comparison with serous carcinoma. Gynecol Oncol 32(1):65–71 Takano M, Kikuchi Y, Yaegashi N, Kuzuya K, Ueki M, Tsuda H, Suzuki M et al (2006) Clear cell carcinoma of the ovary: a retrospective multicenter experience of 254 patients with complete surgical staging. Br J Cancer 94:1369–1374 Ryu SY, Park SI, Nam BH, Kim I, Yoo CW, Nam JH, Lee KH et al (2009) Prognostic significance of histological grade in clear cell carcinoma of the ovary: a retrospective study of Korean gynecologic oncology group. Ann Oncol 20:1032–1036 Behbakht K, Randall TC, Benjamin I, Morgan MA, King S, Rubin SC (1998) Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol 70:255–258 Takano M, Sasaki N, Kita T, Kudoh K, Fujii K et al (2008) Survival analysis of ovarian clear cell carcinoma confined to the ovary with or without comprehensive surgical staging. Oncol Rep 19:1259–1264 Shi M, Zhang Y, Shen K, Lang J, Huang H, Wu M (2002) Clinical characteristics of clear cell carcinoma of the ovary. Zhonghua Fu Chan Ke Za Zhi 37(3):161–163 Conflict of interest None. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Kondi-Pafiti, A., Papakonstantinou, E., Iavazzo, C. et al. Clinicopathological characteristics of ovarian carcinomas associated with endometriosis. Arch Gynecol Obstet 285, 479–483 (2012). https://doi.org/10.1007/s00404-011-1957-z Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-011-1957-z